Home Stocks Dr Reddy’s Laboratories Ltd

Dr Reddy’s Laboratories Ltd

The live share price of Dr Reddy's Laboratories Ltd (DRREDDY) as on 25 Apr 10:14am is ₹6,218.75 from NSE/BSE.

DRREDDY NSE

₹6,218.75 ▲4.5% (267.95)

As on Apr 25, 2024 03:44 PM IST

How do you feel today about Dr Reddy's Laboratories Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

18.95

PB Ratio

4.26

Dividend Yield

0.67%

Sector PB

5.89

Sector PE

51.72

Sector Div Yld

0.55%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Largecap, ₹99,094 Cr

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

The following charts display the financial performance of the Dr Reddy's Laboratories Ltd (DRREDDY) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Dr Reddy's Laboratories Ltd (DRREDDY), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Largecap, ₹99,094 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	25,762 Cr	+16.57%
Operating Expense	2,477 Cr	-9.21%
Net Income	4,507 Cr	+106.52%
Net Profit Margin	17.5%	+77.13%
Earning Per Share	270	+106.38%
EBITDA	7,441 Cr	+72.16%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	6,179 Cr	+39.29%
Total Assets	32,209 Cr	+8.28%
Total Liabilities	8,923 Cr	-15.29%
Total Equity	23,286 Cr	+21.2%
Shares Outstanding	16.65 Cr	+0.04%
Price to Book	3.31	-10.71%
Return on Assets	14.55%	+87.74%
Return on Capital	26.59 Cr	+61.84%

Cash Flows

(INR)		Y/Y Change
Net Income	4,507 Cr	+106.52%
Cash from Operations	5,887 Cr	+109.46%
Cash from Investing	-4,108 Cr	+60.16%
Cash from Financing	-2,686 Cr	+1009.04%
Net Change in Cash	-907 Cr	-28453.12%
Free Cash Flow	4,000 Cr	+341.65%

Shareholding Pattern

Total Promoter Holding

26.65%

Unpledged

Foreign Institutions

44.49%

Foreign Institutions

Retail & Others

10.55%

Retail & Others

Other Parties

Other Domestic Institutions

10.35%

Insurance Firms

Others

Mutual Funds

7.96%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

40.03

1Y Return

▲51.74%

CIPLA

Cipla Ltd

PE Ratio

30.44

1Y Return

▲54.84%

MANKIND

Mankind Pharma Ltd

PE Ratio

55.63

1Y Return

▲68.62%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

31.59

1Y Return

▲85.6%

Latest News

Nestle India, Dr Reddy’s to Form JV for Nutraceutical Brands in India, Other Agreed Territories - News18

9 hours ago on News18

Change since news ▼-INF%

Nestle India and Dr Reddy’s Laboratories Ltd on Thursday announced that they have entered into a definitive agreement to form a joint venture to bring innovative nutraceutical brands to consumers in India and other agreed territories

Trade setup for Friday: 15 things to know before opening bell

1 week ago on Moneycontrol

Change since news ▼-INF%

A short build-up was seen in 100 stocks, including Exide Industries, Indraprastha Gas, Dr Reddy’s Laboratories, Titan Company, and Berger Paints.

Sanofi Looks For Accelerated Growth In India, Plans Fast-Tracking Of Product Pipeline

3 weeks ago on Bloomberg Quint

Change since news ▼-INF%

Sanofi Healthcare India recently tied up with companies like Cipla, Dr Reddy’s Laboratories and Emcure to expand the reach of its products in the country.

FAQs on Dr Reddy's Laboratories Ltd

How to buy Dr Reddy's Laboratories Ltd stocks?

You can easily buy the stocks/shares of Dr Reddy's Laboratories Ltd (DRREDDY) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Dr Reddy's Laboratories Ltd?

The stock price of Dr Reddy's Laboratories Ltd as on 25 Apr 2024 is ₹6,218.75

What is the 52-week High and Low of Dr Reddy's Laboratories Ltd?

The 52-week high and low of Dr Reddy's Laboratories Ltd (DRREDDY) is ₹6,505.9 and ₹4,384.05.

What is the PE and PB ratio of Dr Reddy's Laboratories Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Dr Reddy's Laboratories Ltd are 18.95 and 4.26 respectively.

What are the peers or stocks similar to Dr Reddy's Laboratories Ltd?

The peers or stocks similar to Dr Reddy's Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Dr Reddy's Laboratories Ltd belong to?

Dr Reddy's Laboratories Ltd (DRREDDY) belongs to the Pharmaceuticals sector.

What is the Market Cap of Dr Reddy's Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Reddy's Laboratories Ltd (DRREDDY) is ₹99,094 Cr as of 25 Apr 2024

Can't decide whether or not to buy Dr Reddy's Laboratories Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.